PYC pyc therapeutics limited

PYC Chart and Technical Analysis, page-214

  1. 6,826 Posts.
    lightbulb Created with Sketch. 382
    I guess we do all know why the sp is moving up, but do we?
    The annual report revealed many new large holders, all nominee companies which means instos. And we had a 88m share X trade which is code for someone wanted in, and they found a way. if others want in can they find the same “off market” way? Perhaps not. So they might be buying on market. (Someone is). Also the annual report gave a clear cash position of an awful lot.. .was it $80m … so no raises anytime soon. One extra snippet would be the size of our next R&D rebate might be quite large because if we do the ADOA trial in Australia that spend qualifies whereas the RP11 trial is in the USA.

    And the kidney drug gets real really quickly if we get success with RP11…. And the annual report reported efficacy in humans in a casual way..

    We are off to the first Tues in Nov…. And not the RBA decision.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.20
Change
0.040(3.45%)
Mkt cap ! $699.9M
Open High Low Value Volume
$1.19 $1.20 $1.18 $97.44K 81.86K

Buyers (Bids)

No. Vol. Price($)
1 5000 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.20 19651 3
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.